Adrenal Diseases in Modena: A Patient Registry at Modena University Hospital

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational, longitudinal, single-center study that gathers retrospective and prospective data on patients with adrenal diseases seen at the Modena Adrenal Outpatient Clinic. It records clinical, bio-humoral, radiological information, treatments, and hormone replacement therapies to characterize the patient population and current management. The goal is to integrate this information with existing knowledge to improve diagnosis, treatment, and understanding of risk factors. The study is non-interventional and does not involve drug administration, with a focus on epidemiology and clinical practice patterns in a real-world setting.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Subjects affected by adrenal disease presenting to the Adrenal Diseases Outpatient Clinic of the Endocrinology Unit at the AOU of Modena, who are able to autonomously provide written informed consent

Exclusion Criteria:

* none

Where it's running

• Ospedale Civile di Baggiovara
  Modena, Modena, Italy Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Belzutifan and catecholamine metabolism in pheochromocytoma/paraganglioma

  This study tests whether Belzutifan can change how catecholamines are produced and broken down in adults with pheochromocytoma or paraganglioma.

  Recruiting Phase 2 Cambridge University Hospitals NHS Foundation Trust · Cambridge, Cambridgeshire · NCT07680205

• Evaluating adrenal gland function using a new imaging agent in patients with hormone-related conditions

  This study is testing a new imaging agent to see if it can help find adrenal tumors in adults with hormone-related conditions like hyperaldosteronism or hypercortisolism.

  Recruiting Phase 2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06246357

• Belzutifan as a preoperative option for pheochromocytoma/paraganglioma

  This study tests whether belzutifan can safely help prepare patients with pheochromocytoma or paraganglioma for surgery and reduce catecholamine-related effects.

  Recruiting Phase 4 Xiangya Hospital of Central South University · Changsha, Hunan · NCT07907341

• Tirzepatide after adrenalectomy for MACS

  This study tests whether adding tirzepatide after adrenalectomy helps control blood pressure and improve metabolic health in adults with mild autonomous cortisol secretion.

  Recruiting Phase 2 University of Pittsburgh · Pittsburgh, Pennsylvania · NCT07573163

• Using [18F]FET PET to find ACTH-secreting pituitary microadenomas

  This project tests whether [18F]FET PET scans can better locate ACTH-secreting pituitary microadenomas in adults with Cushing's disease.

  Recruiting Hospices Civils de Lyon · Bron · NCT07463625

• Fluid-based PET imaging to locate ACTH-secreting pituitary adenomas in Cushing disease

  This study tests whether FET PET/CT scanning can accurately locate ACTH-secreting pituitary adenomas in adults with Cushing disease who are planning pituitary surgery.

  Recruiting Early Phase 1 Mayo Clinic · Rochester, Minnesota · NCT07460232

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.